2018 Infectious Disease Diagnostic Technologies and Market Applications
This report provides a detailed analysis of the current and emerging technologies, and their potential applications for the infectious disease testing market, including DNA probes, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scattering, chromatography and several others.
Contains 61 pages
Contains 61 pages
1. MOLECULAR DIAGNOSTICS
a. Technology Overview
b. Amplification Methods
POLYMERASE CHAIN REACTION
Temperature Cyclers
PCR Variations
IMMUNO-PCR
QC-PCR
DAP-PCR
LIGASE CHAIN REACTION
BRANCHED DNA
Q-BETA REPLICASE
NUCLEIC-ACID SEQUENCE-BASED
STRAND DISPLACEMENT ACTIVATION
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
a. Technological Principle
b. Enzyme Immunoassays (EIA)
OVERVIEW
ELISA
DOT IMMUNOBINDING ASSAYS
CAPILLARY IMMUNOASSAYS
PARTICLE-MEMBRANE CAPTURE IMMUNOASSAYS
ENZYME AMPLIFICATION
c. Fluorescent Immunoassays
FLUORESCENCE POLARIZATION
TIME-RESOLVED PULSE FLUORESCENCE
d. Luminescence
CHEMILUMINESCENCE
BIOLUMINESCENCE
e. Latex Agglutination
f. Immunoprecipitation
4. DIFFERENTIAL LIGHT SCATTERING
5. IT
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. MRI
11. GEL MICRODROPLETS
12. OTHER
a. Technology Overview
b. Amplification Methods
POLYMERASE CHAIN REACTION
Temperature Cyclers
PCR Variations
IMMUNO-PCR
QC-PCR
DAP-PCR
LIGASE CHAIN REACTION
BRANCHED DNA
Q-BETA REPLICASE
NUCLEIC-ACID SEQUENCE-BASED
STRAND DISPLACEMENT ACTIVATION
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
a. Technological Principle
b. Enzyme Immunoassays (EIA)
OVERVIEW
ELISA
DOT IMMUNOBINDING ASSAYS
CAPILLARY IMMUNOASSAYS
PARTICLE-MEMBRANE CAPTURE IMMUNOASSAYS
ENZYME AMPLIFICATION
c. Fluorescent Immunoassays
FLUORESCENCE POLARIZATION
TIME-RESOLVED PULSE FLUORESCENCE
d. Luminescence
CHEMILUMINESCENCE
BIOLUMINESCENCE
e. Latex Agglutination
f. Immunoprecipitation
4. DIFFERENTIAL LIGHT SCATTERING
5. IT
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. MRI
11. GEL MICRODROPLETS
12. OTHER